intestinal bacteria (flora)
Introduction
Bacteria present in the intestinal tract.
Also see normal microbial flora.
Classification
- enterotypes[31]
- Bacteroides enterotype (B-type)
- Ruminococcaceae enterotype (R-type)
- Prevotella enterotype (P-type)
* B-type with lower stool energy density, shorter intestinal transit times, & lower alpha-diversity compared to R-type
* P-type intermediate between B-type & R-type[31]
* B-type individuals heavier than R-type
Epidemiology
- men who have sex with men have Prevotella-dominant microbiomes
- Prevotella-dominant microbiome associated with HIV1 infection
- other men have Bacteroides-dominant microbiomes[8]
- Veillonella atypica found in higher concentrations in intestines of marathon runners than in nonathletes[26]
- in middle-age subjects intestinal bacteria were associated with cognitive effects
- Barnesiella with benefit in cognitive testing including
- digital symbol substitution test
- category fluency
- Lachnospiraceae FCS020 group with benefit on digital symbol substitution test
- Sutterella with poorer performance on Montreal Cognitive Assessment[29]
- Barnesiella with benefit in cognitive testing including
Pathology
- intestinal flora appear to be implicated in obesity, dyslipidemia, & insulin resistance[2]
- oral antibiotics reduce microbiome diversity in feces[5]
- specifically, bacteria that produce butyrate* are reduced
- clindamycin reduces microbiome diversity for up to 4 months
- ciprofloxacin reduces microbiome diversity for up to 12 months
- specifically, bacteria that produce butyrate* are reduced
- 24% of non-antibiotic drugs, members of all therapeutic classes, inhibit growth of at least one intestinal strain in vitro[22]
- antipsychotics, other psychoactive agents, proton-pump inhibitors, antineoplastics, & hormones over-represented[22]
- bacteria resistant to various antibiotics also were resistant to inhibiting effects of nonantibiotics[22]
- bacterial mutations that eject antibiotics from bacterial cells also ejected some nonantibiotic drugs[22]
- animal-based diets increase the abundance of bile-tolerant microorganisms (Alistipes, Bilophila, Bacteroides)
- activity of Bilophila wadsworthia associated with an animal-based diet may play a role in triggering inflammatory bowel disease[3]
- plant-based diets increase the abundance of Firmicutes (Roseburia, Eubacterium rectale, Ruminococcus bromii) that metabolize dietary plant polysaccharides[3]
- Fusobacterium nucleatum appears to be implicated in colorectal carcinoma
- Bacteroides species present in intestinal flora of infants may suppress development of tolerance to self-antigens & increase risk of type 1 diabetes[11]
- gut microbial viversity diminishes with increased frailty in community-dwelling elderly & in long-term care residents[13]
- intestinal bacteria of the Ruminococcaceae family & Clostridiales order, & especially of the genus Faecalibacterium confer better response to anti-PD-1 immunotherapy in patients with melanoma[17]
- intestinal bacteria of the Bacteroidales order confer worse response to anti-PD-1 immunotherapy[17]
- responders to immunotherapy for metastatic melanoma with gut microbiome abundant in 8 bacterial species[19]
- recent antibiotics confer worse response in patients with lung cancer, renal cell carcinoma, & urothelial cancer undergoing anti-PD-1 immunotherapy[17]
- abundance of Akkermansia muciniphila associated with the best clinical outcomes[17]
- dietary salt decreases intestinal Lactobacilli in mice & humans & increases blood pressure[18]
- elevated levels of phenylacetylglutamine, a byproduct of microbial break down dietary protein, increases risk of heart failure & severity, & risk of myocardial infarction, stroke & death[30]
- Enterococcus gallinarum may be associated with lupus[21]
- the microbiome may influence development of both obesity & type 2 diabetes,1 both of which are atherogenic[23]
- intestinal bacteria produce neuroactive molecules as well as molecules that influence cells to produce neuroactive agents[24]
- metabolism of intestinal bacteria appear to be linked to functional status & mood, possibly influencing depression[24]
- 47 specific bacterial species, 3 specific bacteriophages, & 50 fecal metabolites are significantly associated with major depression[27]
- among the 50 metabolites gamma-aminobutyrate, phenylalanine & tryptophan enter the blood from the gut, affect neurochemistry, & have been implicated in major depression[27]
* butyrate-producing bacteria are linked to lower inflammation, carcinogenesis, & oxidative stress in the gut[5]
Genetics
- for some bacteria, i.e. Bacteroidetes, environmental influences are much greater than genomic influences[4]
- for bacteria, i.e. Christensenellaceae, the opposite was true
- Christensenellaceae appear to protect against obesity[4]
Pharmacology
- some bacteria can store a drug without chemically modifying it
- other bacteria chemically modify it to make it more or less bioactive
- a drug can affect a patient's gut bacteria, their number & function
- accumulation of a drug within a strain of bacteria can alter the growth rate of those bacteria
- a drug can change molecules secreted by bacteria, including hormones, neurotransmitters, & inflammatory molecules[28]
- communities of intestinal bacteria influence response to checkpoint inhibitors in patients with non-small cell lung carcinoma[35]
Physiology
- small intestine
- Lactobacillus spp (3+)
- Bacteroides spp (3+)
- Clostridium spp (2+)
- Mycobacterium spp (2+)
- Enterococci (2+)
- Enterobacteriaceae (2+)
- large intestine
- Bacteroides spp (4+)
- Fusobacterium spp
- Fusobacterium nucleatum may be increased in patients with colon cancer
- Ruminococcaceae
- Ruminococcus (neuroprotective)
- Butyricicoccus (neuroprotective)
- Clostridium spp (4+)
- Peptostreptococcus spp (4+)
- Enterobacteriaceae (4+)
- Lactobacillus spp (3+)
- Enterococci (2+)
- Streptococci
- Pseudomonas spp (1+)
- Acinetobacter spp
- coagulase-negative staphylococci (1+)
- Staphylococcus aureus (1+)
- Mycobacterium spp (1+)
- Actinomyces spp
* the adherens junctions of the intestinal epithelium provide a barrier to the movement of intestinal bacteria from the gut lumen into tissues & the circulation
* exercise increases diversity of gut microbiota[9][19]
- diet also plays a role[9]
* antibiotic or probiotic use affects gut microbiota[19]
* fecal transplantation alters gut microbiota[19]
* estimated weight of microbial flora in human gut is 1-1.4 kg
* an infant's intestinal flora is strongly influenced by the mother's intestinal flora during vaginal delivery
* in life a person's intestinal flora is influenced by diet & lifestyle
* gut microbiota similiar in health aged & health young Chinese[16]
Comparative biology
- nonpathogenic Clostridia (17 strains) normally found in human intestinal flora can suppress immunologically mediated disease in mice
- the Clostridial strains induce CD4+FOXP3+ regulatory T-cells
- promise for treatment of inflammation & allergy
- fecal transplantation from mice with anti-melanoma immunity augments responses to anti-PDL1 immunotherapy[6]
- augmented response apparently conferred by Bifidobacterium
- probiotic therapy with Bifidobacterium species prevented or ameliorated autoimmune colitis in a mouse melanoma model[20]
- effect mediated by regulatory T cells (CTLA4 inhibition)[20]
- fecal transplantation into mice from patients treated with ipilimumab enhances responses of mice to anti-CTLA4 therapy[7]
- high-glycemic index diets worsen macular deneration in mice
- low glycemic index diets arrest progession of macular deneration in mice
- changes dependent on changes in the gut microbiome[14]
- lipopolysaccharide (LPS) produced by gram-negative bacteria can penetrate the gut mucosa during inflammation & can enter the circulation in mice[15]
- LPS stimulates TKR4 on the endothelial wall of cerebral blood vessels & this triggers morphologic changes that evolve into serebral cavernous malformations, strokes & seizures[15]
- Enterococcus gallinarum can penetrate intestinal epithelium, translocate to mesenteric lymph nodes & liver, resulting in condition similar to systemic lupus erythematosus in mice[21]
- prebiotic (10% oligofructose-enriched inulin) fed to mice altered gut microbiota in young & middle-aged mice with changes correlating with fecal metabolites; Functionally, this translated into a reversal of stress-induced immune priming in middle-aged mice, reduction of infiltration of monocytes inro brain & a reversal in ageing-related increases in a subset of activated microglia[25]
- microbiome-dependent production of endocannabinoid metabolites in the gut stimulates activity of TRPV1-expressing sensory neurons thus elevating dopamine levels in the ventral striatum during exercise in mice[32]
- in 3xTg-AD mice, Klebsiella pneumoniae can translocate from the gut to the bloodstream by penetrating the gut epithelial barrier & susequently infiltrate the brain by penetrating the blood-brain barrier[36]
Notes
- Lactobacillus rhamnosus GG strain may benefit memory[33]
- Prevotella may negatively impact memory[33]
- for resistant isolates of enteric bacteria, report to EntericBacteria@cdc.gov
More general terms
Additional terms
Component of
References
- ↑ Atarashi K, Tanoue T, Oshima K et al Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013 Aug 8;500(7461):232-6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23842501
- ↑ 2.0 2.1 Ridaura VK et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013 Sep 6; 341:1079 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24009397 <Internet> http://www.sciencemag.org/content/341/6150/1241214
Le Chatelier E et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013 Aug 29; 500:541. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23985870
Cotillard A et al. Dietary intervention impact on gut microbial gene richness. Nature 2013 Aug 29; 500:585 PMID: https://www.ncbi.nlm.nih.gov/pubmed/2398587 - ↑ 3.0 3.1 3.2 David LA et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014 Jan 23; 505:559 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24336217 <Internet> http://www.nature.com/nature/journal/v505/n7484/full/nature12820.html
- ↑ 4.0 4.1 4.2 Goodrich JK et al. Human genetics shape the gut microbiome. Cell 2014 Nov 6; 159:789 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25417156
- ↑ 5.0 5.1 5.2 Zaura E et al Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces. mBio Nov 10, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26556275 <Internet> http://mbio.asm.org/content/6/6/e01693-15.full
- ↑ 6.0 6.1 Sivan A, Corrales L, Hubert N et al Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015 Nov 27;350(6264):1084-9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26541606
- ↑ 7.0 7.1 Vetizou M, Pitt JM, Daillere R et al Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015 Nov 27;350(6264):1079-84 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26541610
- ↑ 8.0 8.1 Noguera-Julian M et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 2016 Mar; 5:135 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27077120 Free PMC Article <Internet> http://www.ebiomedicine.com/article/S2352-3964%2816%2930028-7/abstract
- ↑ 9.0 9.1 9.2 Clarke SF et al Exercise and associated dietary extremes impact on gut microbial diversity. Gut. June 9, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25021423 <Internet> http://gut.bmj.com/content/early/2014/04/29/gutjnl-2013-306541
Hold GL The gut microbiota, dietary extremes and exercise. Gut. June 9, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25021422 <Internet> http://gut.bmj.com/content/early/2014/05/28/gutjnl-2014-307305.extract - ↑ 10.0 10.1 Kraehenbuhl JP & Corbett M, Immunology. Keeping the gut microflora at bay. Science 303, 1624, 2004 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15016988
- ↑ 11.0 11.1 Vatanen T, Kostic AD, d'Hennezel E et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 2016 May 5; 165:842. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27259157
- ↑ Lynch SV, Pedersen O The Human Intestinal Microbiome in Health and Disease. N Engl J Med 2016; 375:2369-2379. December 15, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27974040 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMra1600266
- ↑ 13.0 13.1 Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-184 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22797518
- ↑ 14.0 14.1 Rowan S, Jiang S, Korem T et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A 2017 May 15; http://www.pnas.org/content/early/2017/05/09/1702302114
- ↑ 15.0 15.1 15.2 Tang AT, Choi JP, Kotzin JJ et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 2017 May 18; 545:305. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28489816 https://www.nature.com/nature/journal/v545/n7654/full/nature22075.html
- ↑ 16.0 16.1 Bian G, Gloor GB, Gong A et al The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere. 2017 Oct <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28959739 Free PMC Article <Internet> http://msphere.asm.org/content/2/5/e00327-17
- ↑ 17.0 17.1 17.2 17.3 17.4 Minerd J. Does Gut Flora Impact the Response to Cancer Immunotherapy? Modulating the microbiome could boost therapy, studies suggest. MedPage Today. November 07, 2017 https://www.medpagetoday.com/hematologyoncology/myeloma/69098
Gopalakrishnan V, Spencer CN, Nezi L et al Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2017 Nov 2. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29097493
Routy B, Le Chatelier E, Derosa L et al Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2017 Nov 2. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29097494 - ↑ 18.0 18.1 Wilck N, Matus MG, Kearney SM et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature 2017 Nov 30; 551:585. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29143823 https://www.nature.com/articles/nature24628
Relman DA. Microbiota: A high-pressure situation for bacteria. Nature 2017 Nov 30; 551:571 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29143820 https://www.nature.com/articles/nature24760 - ↑ 19.0 19.1 19.2 19.3 19.4 Castellino AM Manipulating Gut Microbiome to Improve Immunotherapy Response. Medscape - Jan 10, 2018. https://www.medscape.com/viewarticle/891152
Jobin C Precision medicine using microbiota. Science 2018 359(6371):32-34. Jan 5 2018: <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29302001 <Internet> http://science.sciencemag.org/content/359/6371/32 - ↑ 20.0 20.1 20.2 Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci U S A 2018 Jan 2; 115:157 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29255057 <Internet> http://www.pnas.org/content/115/1/157
- ↑ 21.0 21.1 21.2 Mohanan V, Nakata T, Desch AN et al. Clorf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 2018 Mar 9; 359:1161. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29420262
Manfredo Vieira S, Hiltensperger M, Kumar V et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018 Mar 9; 359:1156. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29590047
Thaiss CA, Levy M, Grosheva I et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 2018 Mar 23; 359:1376. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29519916
Citi S et al. Intestinal barriers protect against disease. Science 2018 Mar 9; 359:1097 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29590026 - ↑ 22.0 22.1 22.2 22.3 22.4 Maier L, Pruteanu M, Kuhn M et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018 Mar 29; 555:623. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29555994 https://www.nature.com/articles/nature25979
- ↑ 23.0 23.1 Komaroff AL The Microbiome and Risk for Atherosclerosis JAMA. Published online May 14, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29800043 https://jamanetwork.com/journals/jama/fullarticle/2681622
- ↑ 24.0 24.1 24.2 Valles-Colomer M, Falony G, Darzi Y et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019 Feb 4; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30718848 https://www.nature.com/articles/s41564-018-0337-x
- ↑ 25.0 25.1 Boehme M, van de Wouw M, Bastiaanssen TFS et al Mid-life microbiota crises: middle age is associated with pervasive neuroimmune alterations that are reversed by targeting the gut microbiome. Mol Psychiatry. 2019 May 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31092898
- ↑ 26.0 26.1 Scheiman J, Luber JM, Chavkin TA et al. Meta-omics analysis of elite athletes identifies a performance- enhancing microbe that functions via lactate metabolism. Nat Med 2019 Jul; 25:1104. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31235964 https://www.nature.com/articles/s41591-019-0485-4
- ↑ 27.0 27.1 27.2 Yang J, Zheng P, Li Y et al. Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv 2020 Dec 2; 6:eaba8555 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33268363 PMCID: PMC7710361 Free PMC article https://advances.sciencemag.org/content/6/49/eaba8555
- ↑ 28.0 28.1 Klunemann M, Andrejev S, Blasche S et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 2021 Sep; 597:533 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34497420 https://www.nature.com/articles/s41586-021-03891-8
- ↑ 29.0 29.1 Meyer K, Lulla A, Debroy K et al Association of the Gut Microbiota With Cognitive Function in Midlife. JAMA Netw Open. 2022;5(2):e2143941. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35133436 PMCID: PMC8826173 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788843
- ↑ 30.0 30.1 Hughes S Product of Gut Microbiome Implicated in Heart Failure Risk. Medscape. Dec 22, 2022 https://www.medscape.com/viewarticle/986052
Romano KA, Nemet I, Saha PP et al Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure. Circulation: Heart Failure. 2022. Dec 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36524472 https://www.ahajournals.org/doi/abs/10.1161/CIRCHEARTFAILURE.122.009972 - ↑ 31.0 31.1 31.2 Boekhorst J, Venlet N, Prochazkova N et al Stool energy density is positively correlated to intestinal transit time and related to microbial enterotypes. Microbiome 2022. 10:223. Dec 12 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36510309 PMCID: PMC9743556 Free PMC article https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-022-01418-5
- ↑ 32.0 32.1 32.2 Watkins D Science Reveals Link Between Gut Health and Exercise Motivation. Medscape. January 05, 2023 https://www.medscape.com/viewarticle/986535
Dohnalova L, Lundgren P, Carty JRE et al A microbiome-dependent gut - brain pathway regulates motivation for exercise. Nature. 2022 Dec;612(7941):739-747. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36517598 https://www.nature.com/articles/s41586-022-05525-z.epdf - ↑ 33.0 33.1 33.2 Fauzia M A Common Probiotic Could Boost Brain Health in Older Adults. https://www.msn.com/en-us/health/medical/a-common-probiotic-could-boost-brain-health-in-older-adults/ar-AA1ehttK
- ↑ Singh S, Giron LB, Shaikh MW et al. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging. Microbiome. 2024 Feb 22;12(1):31. doi:http://dx.doi.org/ 10.1186/s40168-024-01758-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38383483 PMCID: PMC10882811 Free PMC article.
- ↑ 35.0 35.1 Guglielmi G Gut microbiome discovery provides roadmap for life-saving cancer therapies. The balance between bacterial communities in the gut affects the likelihood of a positive response to drugs called checkpoint inhibitors. Nature News. June 24, 2024 https://www.nature.com/articles/d41586-024-02070-9
Derosa L, Iebba V, Silva CAC et al. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. Cell. 2024. Jun 20;187(13):3373-3389.e16 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38906102 Free article. https://www.cell.com/cell/fulltext/S0092-8674(24)00538-5 - ↑ 36.0 36.1 Park G, Kadyan S, Hochuli N et al An Enteric Bacterial Infection Triggers Neuroinflammation and Neurobehavioral Impairment in 3xTg-AD Transgenic Mice. J Infect Dis. 2024 Sep 10;230(Supplement_2):S95-S108. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39255397